NCT06522542View on ClinicalTrials.gov

Gastric Cancer Complicated With Bleeding

Not yet recruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2026

Conditions

Gastric Cancer

Interventions

DRUG

systematic therapy

All patients received systematic therapy including chemotherapy, targeted therapy or immune checkpoint inhibitor. We aims to investigate the impact of bleeding on the survival and treatment-related adverse events (TRAEs) of gastric cancer patients.

All Listed Sponsors

lead

Peking University Third Hospital

OTHER

NCT06522542 - Gastric Cancer Complicated With Bleeding | Biotech Hunter | Biotech Hunter